Literature DB >> 25854469

[Efficacy and safety of generic imatinib mesylate capsules produced in China for newly diagnosed chronic myeloid leukemia in chronic phase patients].

Juan Chen1, Li Zhou1, Shenghong Du1, Hongying Lu1, Shujun Sun1, Junmin Li1, Weili Zhao1, Zhixiang Shen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25854469     DOI： 10.3760/cma.j.issn.0253-2727.2015.03.013

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN： 0253-2727


× No keyword cloud information.
  1 in total

1.  [Analysis of correlation between plasma trough level and response of generic imatinib in the treatment of Chinese patients with chronic myeloid leukemia].

Authors:  J H You; J Chen; L Zhou; S H Du; H Y Lu; S J Sun; J M Li; Z X Shen
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-11-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.